KLP Kapitalforvaltning’s Integra LifeSciences IART Stock Holding History

KLP Kapitalforvaltning’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Hold	14,200	–	–	﹤0.01%	1805
2026 Q1	$134K	Hold	14,200	–	–	﹤0.01%	1968
2025 Q4	$176K	Buy	14,200 +1,600	+13%	+$21.3K	﹤0.01%	1883
2025 Q3	$181K	Hold	12,600	–	–	﹤0.01%	1863
2025 Q2	$155K	Hold	12,600	–	–	﹤0.01%	1878
2025 Q1	$277K	Sell	12,600 -2,500	-17%	-$58.8K	﹤0.01%	1597
2024 Q4	$342K	Buy	+15,100	New	+$330K	﹤0.01%	1575

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

KLP Kapitalforvaltning's IART Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Integra LifeSciences (IART) position steady in Q2 2026 at 14,200 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1805.

KLP Kapitalforvaltning first reported a position in IART in Q4 2024 and has held it in 7 quarters since. The position peaked at $342K in Q4 2024. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

KLP Kapitalforvaltning held 14,200 shares of Integra LifeSciences worth $255K as of Q2 2026.
KLP Kapitalforvaltning left its Integra LifeSciences share count unchanged in Q2 2026.
Integra LifeSciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1805 holding.
KLP Kapitalforvaltning first reported a position in Integra LifeSciences in Q4 2024 and has held it in 7 quarters since.
KLP Kapitalforvaltning's Integra LifeSciences position peaked at $342K in Q4 2024.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.